Allianz Global Investors Fund - Allianz Europe Equity Growth WT4 EURRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 4.3 | |
+/-Cat | - | - | - | - | 0.4 | |
+/-B’mrk | - | - | - | - | -3.3 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar DM Europe Grt T... |
Key Stats | ||
NAV 17/10/2024 | EUR 1211.29 | |
Day Change | -0.15% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
ISIN | LU2676398766 | |
Fund Size (Mil) 17/10/2024 | EUR 3556.17 | |
Share Class Size (Mil) 17/10/2024 | EUR 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 30/09/2023 | 1.09% |
Investment Objective: Allianz Global Investors Fund - Allianz Europe Equity Growth WT4 EUR |
Long-term capital growth by investing in European equity markets with a focus on growth stocks. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Andreas Hildebrand 10/10/2023 | ||
Giovanni Trombello 10/10/2023 | ||
Click here to see others | ||
Inception Date 26/09/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Europe LargeMidCap Growth NR USD | Morningstar DM Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Europe Equity Growth WT4 EUR | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 7.73 |
ASML Holding NV | Technology | 7.71 |
DSV AS | Industrials | 4.80 |
SAP SE | Technology | 4.34 |
Sika AG | Basic Materials | 4.15 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Europe Equity Growth WT4 EUR |